Health Headlines: Lancet Rejects Inquiry, CBD Law Updates, and Device Coverage Accelerations
Published on: April 25, 2026, 2:29 a.m. | Source: Devdiscourse
The Lancet medical journal will not provide evidence for a U.S. Senate COVID-19 inquiry. President Trump urges Congress to update laws for CBD product access. U.S. health regulators plan to expedite Medicare device coverage. The UK investigates data sales on Alibaba. Edwards Lifesciences and Sanofi report earnings, and the FDA fast-tracks psychedelic drug approvals.
